Fact check
“In 2022, the Biden administration launched an inquiry seeking to reschedule marijuana.”
Reasoning
The provided excerpt explicitly says that in 2022 the Biden administration launched an inquiry seeking to reschedule marijuana. This directly supports the claim. No additional sources were supplied to corroborate or refute the statement, so the assessment is based solely on this evidence.
On confidence: The claim is directly stated in a Tier 1 primary source (Reason article) that reports the Biden administration launched an inquiry in 2022 to reschedule marijuana. No contradictory evidence was found, but verification relies on a single media source.
Important context
The article also mentions that the policy was continued by the Trump administration, which may reflect a timeline inconsistency, but does not affect the core claim about the 2022 Biden inquiry.
Evidence
Supporting (1)
- Tier 1 — Primary sourceThe way the FDA and DEA ban drugs is unaccountable and arbitrary
shown potential for use in experimental psychology but have to go through lengthy approval processes before they can be used in tests. Reason 's Jacob Sullum has written how the federal ban on MDMA has prevented labs from finalizing…
Limitations
Assessment is limited to the single Reason article; no official government documents or multiple independent reports were consulted. The source’s accuracy cannot be independently confirmed within the provided evidence.
- Last verified:
- Oct 1, 2026, 4:11 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
The Way the FDA and DEA Ban Drugs Is Unaccountable and ArbitraryReason · Ryan Curtis